Knee Bursitis Market 2026–2030: Emerging Trends and Forecast Opportunities

Uncover key drivers, emerging technologies, and competitive movements shaping the knee bursitis market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Knee Bursitis Market?

The knee bursitis market has experienced significant growth in recent years. It is projected to expand from $2.86 billion in 2025 to $3.06 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.3%. This past growth can be attributed to several factors, including an increased incidence of knee injuries and repetitive stress conditions, rising participation in sports and physical activities, the established use of imaging in musculoskeletal diagnosis, a growing aging population with joint disorders, and the availability of anti-inflammatory medications.

The knee bursitis market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $3.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. Factors driving this growth during the forecast period include an escalating demand for minimally invasive treatments, a heightened emphasis on early diagnosis and preventative measures, the increasing uptake of physiotherapy services, the development of orthopedic care infrastructure, and enhanced availability of diagnostic imaging in developing economies. Key trends observed within the forecast timeframe encompass a rising preference for non-surgical approaches to knee bursitis management, a greater reliance on imaging for precise diagnostic purposes, the increasing integration of physical therapy and rehabilitation, the expansion of outpatient and conservative treatment options, and improved patient understanding regarding prompt care for knee injuries.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which Drivers Are Supporting The Rise Of The Knee Bursitis Market?

The rising occurrence of bone-related conditions is anticipated to fuel the expansion of the knee bursitis market in the future. These conditions, including osteoporosis, arthritis, and bone cancer, compromise the skeletal system’s structure, strength, and functionality. Their growing prevalence stems from factors like an aging populace, inactive lifestyles, inadequate nutrition, and shifts in the environment. Specifically, conditions like osteoarthritis and rheumatoid arthritis can trigger knee bursitis by inducing inflammation and undue strain on the knee bursa, leading to pain, swelling, and diminished joint movement. As an illustration, Healthy Bones Australia reported in October 2024 that approximately 6.2 million Australians aged 50 and above, representing about 67% of that demographic, suffered from poor bone health. This figure is predicted to climb significantly to around 7.7 million individuals with osteopenia or osteoporosis by 2033. Consequently, the increasing prevalence of bone-related diseases is driving the growth of the knee bursitis market.

Knee Bursitis Market Driver: Rising Diabetic Population Fuels Growth In Knee Bursitis Market

What Segments Are Identified Within The Structure Of The Knee Bursitis Market?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Which Leading Companies Dominate The Knee Bursitis Market Share?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Knee Bursitis Market?

North America was the largest region in the knee bursitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Knee Bursitis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Browse Through More Reports Similar to the Global Knee Bursitis Market 2026, By The Business Research Company

Knee Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report

Gouty Arthritis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Osteoarthritis Market Report 2026

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795